Keywords: goldman, sachs, analysts, review, prospects, japanese, pharmaceutical

Goldman Sachs analysts review prospects for Japanese pharmaceutical firms

Article | 14 December 1999

Print This

Analysts from Goldman Sachs have visited a number of pharmaceuticalcompanies in Japan and have issued a report on the progress ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in